Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mesothelioma × olaparib × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3 Other solid neoplasm 3 NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 4 Pheochromocytoma 2 Paraganglioma 2 Thymoma 1 Mesothelioma 1 Meningioma 1 Medulloblastoma 1 EGFR-Mutated Non-Small-Cell Lung Carcinoma 1 Carcinoid Tumor 1 Adrenal Gland Neoplasms 1

Interventions

Nivolumab 2 pembrolizumab 1 olaparib 1 fludarabine phosphate 1 fludarabine 1 PM 01183 1 LY2940680 1 Irinotecan 1 IPI-549 1 Fluorodeoxyglucose F18 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04375267 2023-11-14

LuPARP

Vastra Gotaland Region

Phase 1 Unknown

EndocrineNETOther solid neoplasmThoracic

Mesothelioma, Thymoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡